What does the Chinese military want with your unborn baby’s genetic data?
By Arwa Mahdawi,
The Guardian
| 07. 10. 2021
The BGI group has used data from its popular prenatal test to help the People’s Liberation Army improve ‘population quality’ but they are far from the only ones normalizing eugenics
Your unborn baby is already being monetized
Could data harvested from millions of pregnant women pave the way for genetically enhanced super-soldiers? According to a recent Reuters investigation, BGI Group, the manufacturers of a popular prenatal test, is working with the Chinese military towards that very goal.
BGI group offers a test called Nifty (“Non-Invasive Fetal TrisomY”), which is offered in more than 50 countries and is used to look for genetic abnormalities such as Down’s syndrome early on in a pregnancy. According to Reuters, more than 8 million women have taken these tests, and BGI has used the genetic data it has collected to help the Chinese military improve “population quality”. Reuters reports that US government advisers have warned that access to this massive databank could “propel China to dominate global pharmaceuticals, and also potentially lead to genetically enhanced soldiers, or engineered pathogens to target the US population or food supply”. BGI has issued a statement rejecting these claims.
“China is stealing your intimate data for evil purposes” is a popular genre in western journalism – see, for...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...